PT-141, also known as bremelanotide, is a synthetic cyclic peptide that acts on melanocortin receptors. It is studied in neuroendocrine research involving central melanocortin signaling and receptor-mediated behavioral pathways. Bremelanotide is also the active ingredient in an FDA-approved prescription medication for a specific indication; research materials should not be described as interchangeable with that medication.
Research Focus: Melanocortin receptor activity, neuroendocrine signaling, and central nervous system pathways.
Product Format: Freeze-dried (lyophilized) powder
Handling & Storage: Store sealed in a cool, dry environment protected from direct light. Following laboratory reconstitution, maintain under appropriate refrigerated research-storage conditions.
FOR LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE.